Request Trial
panel-1-reading-between-the-lines
26 May 2026VideosEuropeStephen Garner, Mathys & Squire | Philippa Griffin, Mathys & Squire

WATCH: Reading between the lines—claim interpretation at the EPO post-G1/24

The EPO's approach to claim interpretation has shifted significantly following the G1/24 decision. This session unpacks how Technical Boards of Appeal are newly applying the mandate to consult descriptions and drawings, and what this means for drafting and opposition strategy.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
UPC hands Occlutech second win against Chinese medtech company in a month
19 June 2026   The court overturns a decision granting the German-based company provisional measures and ordering a Chinese medtech rival to stop selling its device in four European countries.
Europe
Exclusive: ‘Cultural differences are an asset’ at the UPC
16 June 2026   In the second of a series of interviews with women judges at the pan-European court, Ulrike Voß talks to Sarah Speight about her career, her views on the court so far, and how more women could be encouraged to join the judiciary.
Europe
Siemens ordered to recall mammography device across European countries
11 June 2026   The UPC has dealt Siemens a loss against a rival US medtech company, upholding a key breast imaging patent and addressing a range of issues from infringement and validity to recall orders and software-based workarounds.


Editor's picks

Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

Editor's picks

Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026

More features

Kirkland clears conflicts hurdle in trade secrets spat
Former senior attorney-advisor to ITC commissioners joins Mintz
Novo’s Dutch win sends ‘clear message’ to unapproved semaglutide sellers
Brown Rudnick lands largest lateral IP team hire in firm history
Fran Salisbury: ‘There’s nothing quite like finding the missing piece’
K&L Gates expands European practice with Munich team hire
Patent litigator joins Baker Botts in London as UPC grows in significance
Exclusive: Winston Taylor’s UK head of IP on pitching $1.75bn firm’s ‘humble, but lethal’ practice